Carrier-Free Self-Assembled Nanoparticles for Triple-Amplified Tumor Chemodynamic Therapy and Cuproptosis Induction.

Cheng, Jiamin; Chen, Siyu; Geng, Meijuan; Wei, Xuan; Meng, Siyu; Gong, Liyang; Chen, Keying; Wang, Ziyan et al. · Adv Healthc Mater · 2025

basic_science · Level V

Where this comes from

Abstract

Chemodynamic therapy (CDT) holds great promise in cancer treatment, whereas its efficacy is severely compromised by the low concentration of endogenous hydrogen peroxide(H<sub>2</sub>O<sub>2</sub>), insufficient exogenous catalytic ions, and the presence of high levels of cellular glutathione (GSH). Herein, a dissociable, tumor cell membrane-camouflaged carrier-free nanoparticle is developed through the molecular interaction of copper ions (Cu<sup>2+</sup>), dequalinium (DQ), and β-Lapachone (β-Lap). Upon homotypic tumor targeting, the system releases Cu<sup>2+</sup> (exogenous catalytic ions), β-Lap (H<sub>2</sub>O<sub>2</sub> donor), and DQ (GSH scavenger), achieving triple amplification of CDT efficacy. Concurrently, the intracellular accumulation of Cu<sup>2+</sup> induces cuproptosis, thereby synergistically augmenting CDT efficacy and strikingly restraining tumor growth. Overall, the integration of Cu<sup>2+</sup> supplementation, H<sub>2</sub>O<sub>2</sub> self-supplying, and GSH depletion offers a promising avenue for improving cancer treatment outcomes and paves a new way for multimodal cancer therapy.

Medical subject headings